A Randomized Prospective Non-Inferiority Trial of Sentinel Lymph Node Biopsy in Early Breast Cancer: Blue Dye Compared with Indocyanine Green Fluorescence Tracer.
Michel CoibionFabrice OlivierAudrey CourtoisNathalie MaesVéronique JossaGuy JerusalemPublished in: Cancers (2022)
ICG represents a new promising tracer to detect sentinel lymph nodes in early breast cancer with a detection rate similar to other conventional tracers, and is associated with easy learning and low cost. Our result suggest that this technique is a good alternative to avoid radioactive isotope manipulation.
Keyphrases
- early breast cancer
- sentinel lymph node
- lymph node
- low cost
- positron emission tomography
- pet imaging
- neoadjuvant chemotherapy
- early stage
- study protocol
- phase iii
- clinical trial
- fluorescence imaging
- single molecule
- phase ii
- ultrasound guided
- fine needle aspiration
- computed tomography
- label free
- real time pcr
- energy transfer
- open label
- photodynamic therapy